CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

NEW YORK, Jan. 24, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up ...

Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.

Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...

Former president George W. Bush took the internet by storm during the 2025 Inauguration of President Donald Trump, where the ...

Kelsey Warren [email protected]  609 218 4053 Investor contact: Lauren Johnson [email protected] ...

Stressed-out teenagers appear to be dragging down the U.S. economy, a new study says. Teenagers suffering from anxiety or ...

Fox News personality Maria Bartiromo has a significant history of conducting favorable interviews with US President- elect Donald Trump and is considered a longtime favorite of his while having ...